|
KIAA0182 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.714000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.110000E-01 |
| Normal-vs-Stage2 |
2.780600E-01 |
| Normal-vs-Stage3 |
2.451000E-01 |
| Normal-vs-Stage4 |
6.738400E-03 |
| Stage1-vs-Stage2 |
3.569400E-01 |
| Stage1-vs-Stage3 |
4.829500E-02 |
| Stage1-vs-Stage4 |
4.985400E-04 |
| Stage2-vs-Stage3 |
1.082420E-01 |
| Stage2-vs-Stage4 |
2.262200E-02 |
| Stage3-vs-Stage4 |
9.684400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.657200E-01 |
| Normal-vs-AfricanAmerican |
7.466600E-01 |
| Normal-vs-Asian |
7.141200E-01 |
| Caucasian-vs-AfricanAmerican |
9.094400E-01 |
| Caucasian-vs-Asian |
7.357200E-01 |
| AfricanAmerican-vs-Asian |
6.646200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.298200E-01 |
| Normal-vs-Female |
9.089400E-01 |
| Male-vs-Female |
7.907200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.672600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.039600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.404000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.235000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.208400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.446600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.033600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.883400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.535960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.998200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.981100E-03 |
| Normal-vs-Grade 2 |
7.885800E-01 |
| Normal-vs-Grade 3 |
2.619600E-01 |
| Normal-vs-Grade 4 |
1.933170E-01 |
| Grade 1-vs-Grade 2 |
2.671800E-02 |
| Grade 1-vs-Grade 3 |
5.021900E-03 |
| Grade 1-vs-Grade 4 |
1.740410E-03 |
| Grade 2-vs-Grade 3 |
8.577800E-02 |
| Grade 2-vs-Grade 4 |
1.219800E-01 |
| Grade 3-vs-Grade 4 |
4.945400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.661400E-01 |
| Normal-vs-ccB subtype |
3.959400E-01 |
| ccA subtype-vs-ccB subtype |
3.205200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.761800E-01 |
| Normal-vs-N1 |
3.651700E-02 |
| N0-vs-N1 |
1.399210E-01 |
|
|
